{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:55:50Z","timestamp":1769604950843,"version":"3.49.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00438-022-01940-z","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T05:02:53Z","timestamp":1661403773000},"page":"1615-1626","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A meta-analysis of different von Hippel Lindau mutations: are they related to retinal capillary hemangioblastoma?"],"prefix":"10.1007","volume":"297","author":[{"given":"Fatemeh","family":"Azimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Aghajani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golnaz","family":"Khakpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9462-118X","authenticated-orcid":false,"given":"Samira","family":"Chaibakhsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"issue":"3","key":"1940_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1442-9071.2010.02241.x","volume":"38","author":"OF Chacon-Camacho","year":"2010","unstructured":"Chacon-Camacho OF, Rodriguez-Dennen F, Camacho-Molina A, Rasmussen A, Alonso-Vilatela E, Zenteno JC (2010) Clinical and molecular features of familial and sporadic cases of von Hippel-Lindau disease from Mexico. Clin Exp Ophthalmol 38(3):277\u2013283","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"1940_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/humu.1380050109","volume":"5","author":"F Chen","year":"1995","unstructured":"Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G, Green J (1995) Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 5(1):66\u201375","journal-title":"Hum Mutat"},{"issue":"5","key":"1940_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s12094-012-0940-x","volume":"15","author":"J Chen","year":"2013","unstructured":"Chen J, Geng W, Zhao Y, Zhao H, Wang G, Huang F, Liu F, Geng X (2013) Clinical and mutation analysis of four Chinese families with von Hippel-Lindau disease. Clin Transl Oncol 15(5):391\u2013397","journal-title":"Clin Transl Oncol"},{"key":"1940_CR4","first-page":"495","volume":"103","author":"EY Chew","year":"2005","unstructured":"Chew EY (2005) Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations. Trans Am Ophthalmol Soc 103:495\u2013511","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"1","key":"1940_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3346\/jkms.2009.24.1.77","volume":"24","author":"HJ Cho","year":"2009","unstructured":"Cho HJ, Ki CS, Kim JW (2009) Improved detection of germline mutations in Korean VHL patients by multiple ligation-dependent probe amplification analysis. J Korean Med Sci 24(1):77\u201383","journal-title":"J Korean Med Sci"},{"issue":"3","key":"1940_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3171\/jns.2004.100.3.0480","volume":"100","author":"D Choo","year":"2004","unstructured":"Choo D, Shotland L, Mastroianni M, Glenn G, van Waes C, Linehan WM, Oldfield EH (2004) Endolymphatic sac tumors in von Hippel\u2014Lindau disease. J Neurosurg 100(3):480\u2013487","journal-title":"J Neurosurg"},{"issue":"1","key":"1940_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086756","volume":"9","author":"J Crona","year":"2014","unstructured":"Crona J, Nordling M, Maharjan R, Granberg D, St\u00e5lberg P, Hellman P, Bj\u00f6rklund P (2014) Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours. PLoS ONE 9(1):e86756","journal-title":"PLoS ONE"},{"issue":"7","key":"1940_CR8","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1136\/jmg.39.7.e38","volume":"39","author":"C Cybulski","year":"2002","unstructured":"Cybulski C, Krzystolik K, Murgia A, Gorski B, D\u0119bniak T, Jakubowska A, Martella M, Kurzawski G, Prost M, Kojder I, Limon J (2002) Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene. J Med Genet 39(7):e38\u2013e38","journal-title":"J Med Genet"},{"issue":"4","key":"1940_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ejhg.2013.180","volume":"22","author":"J Decker","year":"2014","unstructured":"Decker J, Neuhaus C, Macdonald F, Brauch H, Maher ER (2014) Clinical utility gene card for: von Hippel-Lindau (VHL). Eur J Hum Genet 22(4):572\u2013572. https:\/\/doi.org\/10.1038\/ejhg.2013.180","journal-title":"Eur J Hum Genet"},{"issue":"9","key":"1940_CR10","first-page":"3067","volume":"43","author":"H Dollfus","year":"2002","unstructured":"Dollfus H, Massin P, Taupin P, Nemeth C, Amara S, Giraud S, B\u00e9roud C, Dureau P, Gaudric A, Landais P, Richard S (2002) Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study. Invest Ophthalmol vis Sci 43(9):3067\u20133074","journal-title":"Invest Ophthalmol vis Sci"},{"key":"1940_CR11","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1210\/js.2019-00225","volume":"9","author":"GF Fagundes","year":"2019","unstructured":"Fagundes GF, Petenuci J, Lourenco DM Jr, Trarbach EB, Pereira MA, Correa D\u2019Eur JE, Hoff AO, Lerario AM, Zerbini MC, Siqueira S, Yamauchi F (2019) New insights into pheochromocytoma surveillance of young patients with VHL missense mutations. J Endocr Soc 9:1682\u20131692","journal-title":"J Endocr Soc"},{"key":"1940_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2020.02.006","volume":"243","author":"M Faiyaz-Ul-Haque","year":"2020","unstructured":"Faiyaz-Ul-Haque M, Jamil M, Aslam M, Abalkhail H, Al-Dayel F, Basit S, Nawaz Z, Zaidi SH (2020) Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease. Cancer Genet 243:1\u20136","journal-title":"Cancer Genet"},{"issue":"6","key":"1940_CR13","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/S1097-2765(00)80233-6","volume":"4","author":"DE Feldman","year":"1999","unstructured":"Feldman DE, Thulasiraman V, Ferreyra RG, Frydman J (1999) Formation of the VHL\u2013elongin BC tumor suppressor complex is mediated by the chaperonin TRiC. Mol Cell 4(6):1051\u20131061","journal-title":"Mol Cell"},{"key":"1940_CR14","volume-title":"Applied longitudinal analysis","author":"GM Fitzmaurice","year":"2012","unstructured":"Fitzmaurice GM, Laird NM, Ware JH (2012) Applied longitudinal analysis, vol 998. Wiley, Hoboken"},{"issue":"3","key":"1940_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s004390050206","volume":"98","author":"D Glava\u010d","year":"1996","unstructured":"Glava\u010d D, Neumann HP, Wittke C, Jaenig H, Ma\u0161ek O, Streicher T, Pausch F, Engelhardt D, Plate KH, H\u00f6fler H, Chen F (1996) Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe. Hum Genet 98(3):271\u2013280","journal-title":"Hum Genet"},{"issue":"2","key":"1940_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/00207454.2017.1372436","volume":"128","author":"M Glushkova","year":"2018","unstructured":"Glushkova M, Dimova P, Yordanova I, Todorov T, Tourtourikov I, Mitev V, Todorova A (2018) Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene. Int J Neurosci 128(2):117\u2013124","journal-title":"Int J Neurosci"},{"issue":"4","key":"1940_CR17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10689-010-9357-2","volume":"9","author":"I Gomy","year":"2010","unstructured":"Gomy I, Molfetta GA, de Andrade BE, Ferreira CA, Zanette DL, Casali-da-Rocha JC, Silva WA (2010) Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation. Fam Cancer 9(4):635\u2013642","journal-title":"Fam Cancer"},{"issue":"1","key":"1940_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrc3844","volume":"15","author":"L Gossage","year":"2015","unstructured":"Gossage L, Eisen T, Maher ER (2015) VHL, the story of a tumour suppressor gene. Nat Rev Cancer 15(1):55\u201364. https:\/\/doi.org\/10.1038\/nrc3844","journal-title":"Nat Rev Cancer"},{"key":"1940_CR19","first-page":"147","volume":"1","author":"DJ Gross","year":"1996","unstructured":"Gross DJ, Avishai N, Meiner V, Filon D, Zbar B, Abeliovich D (1996) Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene. J Clin Endocrinol Metab 1:147\u2013149","journal-title":"J Clin Endocrinol Metab"},{"issue":"5\u20136","key":"1940_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3109\/08820538.2013.825281","volume":"28","author":"NM Haddad","year":"2013","unstructured":"Haddad NM, Cavallerano JD, Silva PS (2013) Von hippel-lindau disease: a genetic and clinical review. Semin Ophthalmol 28(5\u20136):377\u2013386. https:\/\/doi.org\/10.3109\/08820538.2013.825281","journal-title":"Semin Ophthalmol"},{"issue":"5","key":"1940_CR21","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/aos.14360","volume":"98","author":"A Hajjaj","year":"2020","unstructured":"Hajjaj A, van Overdam KA, Oldenburg RA, Koopmans AE, van den Ouweland AM, de Klein A, Kili\u00e7 E (2020) Retinal haemangioblastomas in von Hippel-Lindau germline mutation carriers: progression, complications and treatment outcome. Acta Ophthalmol 98(5):464\u2013471. https:\/\/doi.org\/10.1111\/aos.14360","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"1940_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s004390000265","volume":"106","author":"F Hes","year":"2000","unstructured":"Hes F, Zewald R, Peeters T, Sijmons R, Links T, Verheij J, Matthijs G, Legius E, Mortier G, Van Der Torren K, Rosman M (2000) Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene. Hum Genet 106(4):425\u2013431","journal-title":"Hum Genet"},{"key":"1940_CR23","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3389\/fgene.2019.00867","volume":"10","author":"B Hong","year":"2019","unstructured":"Hong B, Ma K, Zhou J, Zhang J, Wang J, Liu S, Zhang Z, Cai L, Zhang N, Gong K (2019) Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel-Lindau Disease. Front Genet 10:867","journal-title":"Front Genet"},{"key":"1940_CR24","first-page":"47","volume":"1","author":"Y Huang","year":"2012","unstructured":"Huang Y, Zhou D, Liu J, Zhou P, Li X, Wang Z (2012) Germline mutations of the VHL gene in seven Chinese families with von Hippel-Lindau disease. Int J Mol Med 1:47\u201352","journal-title":"Int J Mol Med"},{"issue":"3","key":"1940_CR25","first-page":"401","volume":"13","author":"K Iida","year":"2004","unstructured":"Iida K, Okimura Y, Takahashi K, Inomata S, Iguchi G, Kaji H, Chihara K (2004) A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred. Int j Mol Med 13(3):401\u2013404","journal-title":"Int j Mol Med"},{"issue":"20","key":"1940_CR26","doi-asserted-by":"publisher","first-page":"10595","DOI":"10.1073\/pnas.93.20.10595","volume":"93","author":"O Iliopoulos","year":"1996","unstructured":"Iliopoulos O, Levy AP, Jiang C, Kaelin WG, Goldberg MA (1996) Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci U S A 93(20):10595\u201310599. https:\/\/doi.org\/10.1073\/pnas.93.20.10595","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1940_CR27","first-page":"879","volume":"14","author":"HC Kang","year":"2005","unstructured":"Kang HC, Kim IJ, Park JH, Shin Y, Jang SG, Ahn SA, Park HW, Lim SK, Oh SK, Kim DJ, Lee KW (2005) Three novel VHL germline mutations in Korean patients with von Hippel-Lindau disease and pheochromocytomas. Oncol Rep 14(4):879\u2013883","journal-title":"Oncol Rep"},{"issue":"24","key":"1940_CR28","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1200\/jco.2004.05.061","volume":"22","author":"WY Kim","year":"2004","unstructured":"Kim WY, Kaelin WG (2004) Role of VHL gene mutation in human cancer. J Clin Oncol 22(24):4991\u20135004. https:\/\/doi.org\/10.1200\/jco.2004.05.061","journal-title":"J Clin Oncol"},{"issue":"4","key":"1940_CR29","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson","year":"1971","unstructured":"Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68(4):820\u2013823. https:\/\/doi.org\/10.1073\/pnas.68.4.820","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1940_CR30","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.ophtha.2006.02.059","volume":"113","author":"KM Kreusel","year":"2006","unstructured":"Kreusel KM, Bechrakis NE, Krause L, Neumann HP, Foerster MH (2006) Retinal angiomatosis in von Hippel-Lindau disease: a longitudinal ophthalmologic study. Ophthalmology 113(8):1418\u20131424. https:\/\/doi.org\/10.1016\/j.ophtha.2006.02.059","journal-title":"Ophthalmology"},{"issue":"1","key":"1940_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-198901000-00001","volume":"68","author":"JM Lamiell","year":"1989","unstructured":"Lamiell JM, Salazar FG, Hsia YE (1989) von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine 68(1):1\u201329","journal-title":"Medicine"},{"issue":"5112","key":"1940_CR32","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260(5112):1317\u20131320. https:\/\/doi.org\/10.1126\/science.8493574","journal-title":"Science"},{"issue":"1","key":"1940_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12881-016-0306-2","volume":"17","author":"JS Lee","year":"2016","unstructured":"Lee JS, Lee JH, Lee KE, Kim JH, Hong JM, Ra EK, Seo SH, Lee SJ, Kim MJ, Park SS, Seong MW (2016) Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-\u03b1 binding site missense mutations elevate age-specific risk for CNS hemangioblastoma. BMC Med Genet 17(1):1\u20138","journal-title":"BMC Med Genet"},{"issue":"5","key":"1940_CR34","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1182\/blood-2018-03-838235","volume":"132","author":"M Lenglet","year":"2018","unstructured":"Lenglet M, Robriquet F, Schwarz K, Camps C, Couturier A, Hoogewijs D, Buffet A, Knight SJ, Gad S, Couv\u00e9 S, Chesnel F (2018) Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease. Blood 132(5):469\u2013483","journal-title":"Blood"},{"issue":"4","key":"1940_CR35","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1469-1809.2011.00647.x","volume":"75","author":"E Leonardi","year":"2011","unstructured":"Leonardi E, Martella M, Tosatto SC, Murgia A (2011) Identification and in silico analysis of novel von Hippel-Lindau (VHL) gene variants from a large population. Ann Hum Genet 75(4):483\u2013496","journal-title":"Ann Hum Genet"},{"issue":"7","key":"1940_CR36","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1530\/EC-18-0167","volume":"7","author":"Q Liu","year":"2018","unstructured":"Liu Q, Yuan G, Tong D, Liu G, Yi Y, Zhang J, Zhang Y, Wang LA, Wang L, Zhang D, Chen R (2018) Novel genotype\u2013phenotype correlations in five Chinese families with Von Hippel-Lindau disease. Endocr Connect 7(7):870\u2013878","journal-title":"Endocr Connect"},{"issue":"3","key":"1940_CR37","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10689-017-0058-y","volume":"17","author":"N Lomte","year":"2018","unstructured":"Lomte N, Kumar S, Sarathi V, Pandit R, Goroshi M, Jadhav S, Lila AR, Bandgar T, Shah NS (2018) Genotype phenotype correlation in Asian Indian von Hippel-Lindau (VHL) syndrome patients with pheochromocytoma\/paraganglioma. Fam Cancer 17(3):441\u2013449","journal-title":"Fam Cancer"},{"issue":"9374","key":"1940_CR38","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/s0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH (2003) von Hippel-Lindau disease. Lancet 361(9374):2059\u20132067. https:\/\/doi.org\/10.1016\/s0140-6736(03)13643-4","journal-title":"Lancet"},{"issue":"1","key":"1940_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2350-14-3","volume":"14","author":"G Losonczy","year":"2013","unstructured":"Losonczy G, Fazakas F, Pfliegler G, Kom\u00e1romi I, Bal\u00e1zs E, P\u00e9nzes K, Berta A (2013) Three novel germ-line VHL mutations in Hungarian von Hippel-Lindau patients, including a nonsense mutation in a fifteen-year-old boy with renal cell carcinoma. BMC Med Genet 14(1):1\u20138","journal-title":"BMC Med Genet"},{"key":"1940_CR40","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","volume":"2","author":"ER Maher","year":"1990","unstructured":"Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA (1990) Clinical features and natural history of von Hippel-Lindau disease. QJM-INT J MED 2:1151\u20131163","journal-title":"QJM-INT J MED"},{"issue":"6","key":"1940_CR41","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ejhg.2010.175","volume":"19","author":"ER Maher","year":"2011","unstructured":"Maher ER, Neumann HP, Richard S (2011) von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet 19(6):617\u2013623. https:\/\/doi.org\/10.1038\/ejhg.2010.175","journal-title":"Eur J Hum Genet"},{"issue":"6733","key":"1940_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399(6733):271\u2013275","journal-title":"Nature"},{"issue":"9","key":"1940_CR43","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1128\/MCB.23.9.3141-3151.2003","volume":"23","author":"MW Melville","year":"2003","unstructured":"Melville MW, McClellan AJ, Meyer AS, Darveau A, Frydman J (2003) The Hsp70 and TRiC\/CCT chaperone systems cooperate in vivo to assemble the von Hippel-Lindau tumor suppressor complex. Mol Cell Biol 23(9):3141\u20133151","journal-title":"Mol Cell Biol"},{"issue":"9","key":"1940_CR44","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1167\/iovs.10-5223","volume":"51","author":"P Mettu","year":"2010","unstructured":"Mettu P, Agr\u00f3n E, Samtani S, Chew EY, Wong WT (2010) Genotype-phenotype correlation in ocular von hippel-lindau (VHL) disease: the effect of missense mutation position on ocular VHL phenotype. Invest Ophthalmol vis Sci 51(9):4464\u20134470. https:\/\/doi.org\/10.1167\/iovs.10-5223","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"4","key":"1940_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1006478","volume":"15","author":"G Minervini","year":"2019","unstructured":"Minervini G, Quaglia F, Tabaro F, Tosatto SC (2019) Genotype-phenotype relations of the von Hippel-Lindau tumor suppressor inferred from a large-scale analysis of disease mutations and interactors. PLoS Comput Biol 15(4):e1006478. https:\/\/doi.org\/10.1371\/journal.pcbi.1006478","journal-title":"PLoS Comput Biol"},{"issue":"18","key":"1940_CR46","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1200\/jco.2015.65.6140","volume":"34","author":"SM Nielsen","year":"2016","unstructured":"Nielsen SM, Rhodes L, Blanco IG, Chung WK, Eng C, Maher E, Richard S, Giles RH (2016) Von Hippel-Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome. J Clin Oncol 34(18):2172\u20132181. https:\/\/doi.org\/10.1200\/jco.2015.65.6140","journal-title":"J Clin Oncol"},{"issue":"5","key":"1940_CR47","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/humu.21219","volume":"31","author":"M Nordstrom-O'Brien","year":"2010","unstructured":"Nordstrom-O\u2019Brien M, van der Luijt RB, van Rooijen E, van den Ouweland AM, Majoor-Krakauer DF, Lolkema MP, van Brussel A, Voest EE, Giles RH (2010) Genetic analysis of von Hippel-Lindau disease. Hum Mutat 31(5):521\u2013537. https:\/\/doi.org\/10.1002\/humu.21219","journal-title":"Hum Mutat"},{"issue":"7","key":"1940_CR48","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/35017054","volume":"2","author":"M Ohh","year":"2000","unstructured":"Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, Huang LE, Pavletich N, Chau V, Kaelin WG (2000) Ubiquitination of hypoxia-inducible factor requires direct binding to the \u03b2-domain of the von Hippel-Lindau protein. Nat Cell Biol 2(7):423\u2013427","journal-title":"Nat Cell Biol"},{"issue":"24","key":"1940_CR49","doi-asserted-by":"publisher","first-page":"38456","DOI":"10.18632\/oncotarget.16594","volume":"8","author":"S Peng","year":"2017","unstructured":"Peng S, Shepard MJ, Wang J, Li T, Ning X, Cai L, Zhuang Z, Gong K (2017) Genotype-phenotype correlations in Chinese von Hippel-Lindau disease patients. Oncotarget 8(24):38456","journal-title":"Oncotarget"},{"issue":"3","key":"1940_CR50","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3171\/jns.2006.104.3.389","volume":"104","author":"A Rasmussen","year":"2006","unstructured":"Rasmussen A, Nava-Salazar S, Yescas P, Alonso E, Revuelta R, Ortiz I, Canizales-Quinteros S, Tusi\u00e9-Luna MT, L\u00f3pez-L\u00f3pez M (2006) Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma. J Neurosurg 104(3):389\u2013394","journal-title":"J Neurosurg"},{"issue":"3","key":"1940_CR51","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1136\/jmg.40.3.e31","volume":"40","author":"JC Rocha","year":"2003","unstructured":"Rocha JC, Silva RL, Mendonca BB, Marui S, Simpson AJ, Camargo AA (2003) High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil. J Med Genet 40(3):e31\u2013e31","journal-title":"J Med Genet"},{"issue":"2","key":"1940_CR52","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/humu.10309","volume":"23","author":"S Ruiz-Llorente","year":"2004","unstructured":"Ruiz-Llorente S, Bravo J, Cebri\u00e1n A, Casc\u00f3n A, Pollan M, Teller\u00eda D, Let\u00f3n R, Urioste M, Rodr\u00edguez-L\u00f3pez R, de Campos JM, Mu\u00f1oz MJ (2004) Genetic characterization and structural analysis of VHL Spanish families to define genotype\u2013phenotype correlations. Hum Mutat 23(2):160\u2013169","journal-title":"Hum Mutat"},{"issue":"1","key":"1940_CR53","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1086\/302726","volume":"66","author":"MT Sgambati","year":"2000","unstructured":"Sgambati MT, Stolle C, Choyke PL, Walther MM, Zbar B, Linehan WM, Glenn GM (2000) Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents. Am J Hum Genet 66(1):84\u201391","journal-title":"Am J Hum Genet"},{"issue":"6","key":"1940_CR54","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1399-0004.2010.01464.x","volume":"79","author":"AD Sorrell","year":"2011","unstructured":"Sorrell AD, Lee S, Stolle C, Ellenhorn J, Grix A, Kaelin WG Jr, Weitzel JN (2011) Clinical and functional properties of novel VHL mutation (X214L) consistent with Type 2A phenotype and low risk of renal cell carcinoma. Clin Genet 79(6):539\u2013545","journal-title":"Clin Genet"},{"key":"1940_CR55","first-page":"117955141770512","volume":"10","author":"C Sriphrapradang","year":"2017","unstructured":"Sriphrapradang C, Choopun K, Tunteeratum A, Sura T (2017) Genotype-phenotype correlation in patients with germline mutations of VHL, RET, SDHB, and SDHD genes: Thai experience. Clin Med Insights: Endocrinol Diabetes 10:1179551417705122","journal-title":"Clin Med Insights: Endocrinol Diabetes"},{"issue":"5413","key":"1940_CR56","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1126\/science.284.5413.455","volume":"284","author":"CE Stebbins","year":"1999","unstructured":"Stebbins CE, Kaelin WG, Pavletich NP (1999) Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 284(5413):455\u2013461","journal-title":"Science"},{"issue":"2","key":"1940_CR57","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/onc.2017.338","volume":"37","author":"D Tarade","year":"2018","unstructured":"Tarade D, Ohh M (2018) The HIF and other quandaries in VHL disease. Oncogene 37(2):139\u2013147. https:\/\/doi.org\/10.1038\/onc.2017.338","journal-title":"Oncogene"},{"issue":"3","key":"1940_CR58","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<337::AID-IJC5>3.0.CO;2-P","volume":"77","author":"E van der Harst","year":"1998","unstructured":"van der Harst E, De Krijger RR, Dinjens WN, Weeks LE, Bonjer HJ, Bruining HA, Lamberts SW, Koper JW (1998) Germline mutations in the vhl gene in patients presenting with phaeochromocytomas. Int J Cancer 77(3):337\u2013340","journal-title":"Int J Cancer"},{"issue":"4","key":"1940_CR59","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10689-015-9806-z","volume":"14","author":"N Vikkath","year":"2015","unstructured":"Vikkath N, Valiyaveedan S, Nampoothiri S, Radhakrishnan N, Pillai GS, Nair V, Pooleri GK, Mathew G, Menon KN, Ariyannur PS, Pillai AB (2015) Genotype\u2013phenotype analysis of von Hippel-Lindau syndrome in fifteen Indian families. Fam Cancer 14(4):585\u2013594","journal-title":"Fam Cancer"},{"issue":"3","key":"1940_CR60","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/archopht.117.3.371","volume":"117","author":"AR Webster","year":"1999","unstructured":"Webster AR, Maher ER, Moore AT (1999) Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol 117(3):371\u2013378. https:\/\/doi.org\/10.1001\/archopht.117.3.371","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"1940_CR61","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/13816810.2014.886265","volume":"35","author":"E Wittstr\u00f6m","year":"2014","unstructured":"Wittstr\u00f6m E, Nordling M, Andr\u00e9asson S (2014) Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease. Ophthalmic Genet 35(2):91\u2013106","journal-title":"Ophthalmic Genet"},{"issue":"2","key":"1940_CR62","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1001\/archopht.125.2.239","volume":"125","author":"WT Wong","year":"2007","unstructured":"Wong WT, Agr\u00f3n E, Coleman HR, Reed GF, Csaky K, Peterson J, Glenn G, Linehan WM, Albert P, Chew EY (2007) Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis. Arch Ophthalmol 125(2):239\u2013245. https:\/\/doi.org\/10.1001\/archopht.125.2.239","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"1940_CR63","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1006\/geno.2000.6144","volume":"65","author":"ER Woodward","year":"2000","unstructured":"Woodward ER, Buchberger A, Clifford SC, Hurst LD, Affara NA, Maher ER (2000) Comparative sequence analysis of the VHL tumor suppressor gene. Genomics 65(3):253\u2013265. https:\/\/doi.org\/10.1006\/geno.2000.6144","journal-title":"Genomics"},{"issue":"4","key":"1940_CR64","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/jhg.2012.10","volume":"57","author":"P Wu","year":"2012","unstructured":"Wu P, Zhang N, Wang X, Ning X, Li T, Bu D, Gong K (2012) Family history of von Hippel-Lindau disease was uncommon in Chinese patients: suggesting the higher frequency of de novo mutations in VHL gene in these patients. J Hum Genet 57(4):238\u2013243","journal-title":"J Hum Genet"},{"issue":"1","key":"1940_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12881-018-0716-4","volume":"19","author":"X Wu","year":"2018","unstructured":"Wu X, Chen L, Zhang Y, Xie H, Xue M, Wang Y, Huang H (2018) A novel mutation in the VHL gene in a Chinese family with von Hippel-Lindau disease. BMC Med Genet 19(1):1\u20135","journal-title":"BMC Med Genet"},{"issue":"2","key":"1940_CR66","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1349-7006.2000.tb00933.x","volume":"91","author":"M Yoshida","year":"2000","unstructured":"Yoshida M, Ashida S, Kondo K, Kobayashi K, Kanno H, Shinohara N, Shitara N, Kishida T, Kawakami S, Baba M, Yamamoto I (2000) Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families. Jpn J Cancer Res 91(2):204\u2013212","journal-title":"Jpn J Cancer Res"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-022-01940-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-022-01940-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-022-01940-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:20:39Z","timestamp":1666743639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-022-01940-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1940"],"URL":"https:\/\/doi.org\/10.1007\/s00438-022-01940-z","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"assertion":[{"value":"29 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent for this study is not necessary.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}